Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Extrapancreatic effects of GIP and GLP-1
A. Vella
, R. A. Rizza
Endocrinology, Diabetes, Metabolism, and Nutrition
Research output
:
Contribution to journal
›
Review article
›
peer-review
47
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Extrapancreatic effects of GIP and GLP-1'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Insulinotropic
100%
Polypeptide
49%
Glucose
44%
Insulin Derivative
34%
Pharmacological Metabolism
19%
Glucagon-Like Peptide 1
13%
Glucagon
11%
Hormone
8%
Medicine & Life Sciences
Glucagon-Like Peptide 1
70%
Incretins
48%
Peptides
38%
Glucose
37%
Insulin
15%
Glucagon
7%
Insulin Secretion
7%
Hyperglycemia
6%
Hormones
5%
Research Personnel
5%
Therapeutics
3%